List View

By /

Clear

Displaying 1,076 - 1,100 of 2,995

Immunotherapy in Metastatic Breast Cancer

Immunotherapy in Metastatic Breast Cancer

Castration Resistant Prostate Cancer (CRPC), Non-Metastatic & Metastatic: Novel Therapeutic Advances

Castration Resistant Prostate Cancer (CRPC), Non-Metastatic & Metastatic: Novel Therapeutic Advances

Neuroendocrine Tumors (NET): Novel Advances in Therapy

Neuroendocrine Tumors (NET): Novel Advances in Therapy

Metastatic Cancer Survivorship Care

Metastatic Cancer Survivorship Care

Thyroid Cancer & Thymic Carcinoma: Recent Advances

Thyroid Cancer & Thymic Carcinoma: Recent Advances

Integrative Oncology in Cancer Care

Integrative Oncology in Cancer Care

Small Cell Lung Cancer: After Immunochemotherapy, What’s Next?

Small Cell Lung Cancer: After Immunochemotherapy, What’s Next?

Adjuvant and Neoadjuvant Novel Concepts and Strategies in NSCLC

Adjuvant and Neoadjuvant Novel Concepts and Strategies in NSCLC

Lung Cancer Clinical Scenarios: How Liquid Biopsy Technology Is Delivering Personalized Therapy in NSCLC

Lung Cancer Clinical Scenarios: How Liquid Biopsy Technology Is Delivering Personalized Therapy in NSCLC

EGFR and K-RAS Mutations in NSCLC

EGFR and K-RAS Mutations in NSCLC

ALK, ROS1 & NTRK Mutations in NSCLC

ALK, ROS1 & NTRK Mutations in NSCLC

ERBB2 and NGR1 Pathways in NSCLC

ERBB2 and NGR1 Pathways in NSCLC

RET, MET & B-RAF mutations in NSCLC

RET, MET & B-RAF mutations in NSCLC

New Agents and New Toxicities in Malignant Hematology: BCL2 Inhibitors, Anti-BCMA, and FLT3 Inhibitors

New Agents and New Toxicities in Malignant Hematology: BCL2 Inhibitors, Anti-BCMA, and FLT3 Inhibitors

De Novo Acute Myeloid Leukemia

De Novo Acute Myeloid Leukemia

Chimeric Antigen Receptor T-Cell Therapy: Indications and Remaining Challenges

Chimeric Antigen Receptor T-Cell Therapy: Indications and Remaining Challenges

Myelodysplasia: Biomarkers, Risk Assessment and Novel Treatments

Myelodysplasia: Biomarkers, Risk Assessment and Novel Treatments

Myeloma, So Many Therapeutic Options in the Relapse Setting: How to Sequence Them?

Myeloma, So Many Therapeutic Options in the Relapse Setting: How to Sequence Them?

CLL: Novel Therapies

CLL: Novel Therapies

Anticoagulation in the Oncology Patient

Anticoagulation in the Oncology Patient

T-Cell NHL: What’s New?

T-Cell NHL: What’s New?

DLBCL & Hodgkin’s Disease: Novel Approaches

DLBCL & Hodgkin’s Disease: Novel Approaches

Follicular Lymphoma: Novel Advances and Pathways

Follicular Lymphoma: Novel Advances and Pathways

Immunotherapy

Immunotherapy

EGFR-Mutated Lung Cancers

EGFR-Mutated Lung Cancers